GeoVax Labs
GOVX
13 hedge funds and large institutions have $1.98M invested in GeoVax Labs in 2021 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 1 closing their positions.
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
300% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 1
30% more funds holding
Funds holding: 10 → 13 (+3)
0% more ownership
Funds ownership: 0.02% → 0.02% (+0%)
0% less capital invested
Capital invested by funds: $1.99M → $1.98M (-$7K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$192K |
| 2 |
Squarepoint
New York
|
+$54K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$52.3K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$31.4K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$12.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$75K |
| 2 |
BlackRock
New York
|
-$1.74K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Vanguard Group
Malvern,
Pennsylvania
| $1.12M | +$12.2K | +7 | +1% |
|
|
2
Geode Capital Management
Boston,
Massachusetts
| $255K | +$31.4K | +18 | +13% |
|
|
GCP
3
GSA Capital Partners
London,
United Kingdom
| $178K | +$192K | +110 | New |
|
4
State Street
Boston,
Massachusetts
| $94K | – | – | – |
|
|
5
BlackRock
New York
| $78K | -$1.74K | -1 | -2% |
|
|
WF
6
Welch & Forbes
Boston,
Massachusetts
| $73K | – | – | – |
|
|
7
Squarepoint
New York
| $51K | +$54K | +31 | New |
|
8
Northern Trust
Chicago,
Illinois
| $50K | – | – | – |
|
|
TSS
9
Two Sigma Securities
New York
| $49K | +$52.3K | +30 | New |
|
10
Wells Fargo
San Francisco,
California
| $12K | – | – | – |
|
11
UBS Group
Zurich,
Switzerland
| $8K | +$8.71K | +5 | New |
|
12
Morgan Stanley
New York
| $7K | +$1.74K | +1 | +25% |
|
|
TRCT
13
Tower Research Capital (TRC)
New York
| $6K | +$3.48K | +2 | +200% |
|
|
14
Citadel Advisors
Miami,
Florida
| – | -$75K | -40 | Closed |
|
GOVX Hedge Fund Activity: Q3 2021 in Review
13 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in GeoVax Labs (GOVX) for Q3 2021, worth a combined $1.98M — down 0.35% from $1.99M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new GOVX positions and 1 closed out — a net gain of 3 holders — while 4 added to existing stakes and 1 trimmed.
The largest buyer was GSA Capital Partners, opening a new position worth an estimated $192K. The largest seller was Citadel Advisors, exiting entirely with an estimated $75K sold.
- 13 institutional investors held GeoVax Labs (GOVX) as of Q3 2021, up from 10 in Q2 2021.
- Funds reported $1.98M of GeoVax Labs stock for Q3 2021, down 0.35% quarter-over-quarter.
- 4 funds opened new GeoVax Labs positions in Q3 2021 and 1 closed out, a net change of +3 holders.
- The largest GeoVax Labs buyer in Q3 2021 was GSA Capital Partners, an estimated $192K added.
- The largest GeoVax Labs seller in Q3 2021 was Citadel Advisors, an estimated $75K sold.
Based on aggregated 13F filings for Q3 2021.